Abstract
Proteasomal degradation of p53 is mediated by two alternative pathways that are either dependent or independent of both Mdm2 and ubiquitin. The ubiquitin-independent pathway is regulated by NAD(P)H: quinone oxidoreductase 1 (NQO1) that stabilizes p53. The NQO1 inhibitor dicoumarol induces ubiquitin-independent p53 degradation. We now show that, like dicoumarol, several other coumarin and flavone inhibitors of NQO1 activity, which compete with NAD(P)H for binding to NQO1, induced ubiquitin-independent p53 degradation and inhibited wild-type p53-mediated apoptosis. Although wild-type p53 and several p53 mutants were sensitive to dicoumarol-induced degradation, the most frequent “hot-spot” p53 mutants in human cancer, R175H, R248H, and R273H, were resistant to dicoumarol-induced degradation, but remained sensitive to Mdm2-ubiquitin-mediated degradation. The two alternative pathways for p53 degradation thus have different p53 structural requirements. Further mutational analysis showed that arginines at positions 175 and 248 were essential for dicoumarol-induced p53 degradation. NQO1 bound to wild-type p53 and dicoumarol, which induced a conformational change in NQO1, inhibited this binding. Compared with wild-type p53, the hot-spot p53 mutants showed increased binding to NQO1, which can explain their resistance to dicoumarol-induced degradation. NQO1 thus has an important role in stabilizing hot-spot p53 mutant proteins in human cancer.
References
38
Referenced
54
10.1038/35042675
10.1038/387296a0
10.1038/387299a0
10.1073/pnas.202480499
10.1073/pnas.98.3.1188
10.1073/pnas.052706799
- Asher G. Lotem J. Sachs L. & Shaul Y. Methods Enzymol. in press.
10.1016/S0021-9258(19)42173-X
10.1074/jbc.M211981200
- Hollstein, M., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith-Sorensen, B., Montesano, R. & Harris, C. C. (1994) Nucleic Acids Res. 22, 3551-3555.7937055 / Nucleic Acids Res. (1994)
10.1016/0092-8674(94)90519-3
10.1126/science.282.5393.1497
10.1093/carcin/14.5.987
10.1038/352345a0
10.1128/mcb.14.3.1997-2003.1994
10.1016/0092-8674(90)90113-S
10.1038/sj.onc.1205319
10.1101/gad.8.15.1739
10.1016/0006-2952(71)90294-2
10.1006/abbi.1993.1182
10.1124/mol.56.2.272
10.1021/bi00118a027
-
Soussi, T. (2000) Ann. N.Y. Acad. Sci. 910, 121-139.10911910
(
10.1111/j.1749-6632.2000.tb06705.x
) / Ann. N.Y. Acad. Sci. (2000) 10.1038/sj.onc.1201459
10.1074/jbc.C000781200
10.1128/MCB.18.10.5690
10.1074/jbc.M102817200
- Malkinson, A. M., Siegel, D., Forrest, G. L., Gazdar, A. F., Oie, H. K., Chan, D. C., Bunn, P. A., Mabry, M., Dykes, D. J., Harrison, S. D., et al. (1992) Cancer Res. 52, 4752-4757.1324793 / Cancer Res. (1992)
10.1007/BF00689804
- Traver, R. D., Horikoshi, T., Danenberg, K. D., Stadlbauer, T. H., Danenberg, P. V., Ross, D. & Gibson, N. W. (1992) Cancer Res. 52, 797-802.1737339 / Cancer Res. (1992)
10.1016/S0891-5849(00)00308-7
10.1021/bi011324i
10.1126/science.1069300
10.1073/pnas.1633591100
10.1016/S0092-8674(03)00552-X
10.1016/S0021-9258(17)36828-X
10.1016/S0092-8674(01)00524-4
10.1016/S0092-8674(01)00527-X
Dates
Type | When |
---|---|
Created | 21 years, 8 months ago (Dec. 9, 2003, 1:17 p.m.) |
Deposited | 1 year, 7 months ago (Jan. 11, 2024, 11:45 a.m.) |
Indexed | 3 months ago (May 19, 2025, 10:05 a.m.) |
Issued | 21 years, 9 months ago (Nov. 21, 2003) |
Published | 21 years, 9 months ago (Nov. 21, 2003) |
Published Online | 21 years, 9 months ago (Nov. 21, 2003) |
Published Print | 21 years, 8 months ago (Dec. 9, 2003) |
@article{Asher_2003, title={p53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1}, volume={100}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.2436329100}, DOI={10.1073/pnas.2436329100}, number={25}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Asher, Gad and Lotem, Joseph and Tsvetkov, Peter and Reiss, Veronica and Sachs, Leo and Shaul, Yosef}, year={2003}, month=nov, pages={15065–15070} }